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Abstract: ABAcard® HemaTrace® kits have been used for crime scene stains for confirmation of
human blood for many years. However, when the stain is too small to allow for separate testing,
confirmatory testing may be forgone to preference DNA analysis. This can lead to court challenges
as to the biological source and therefore probative value of the DNA profile. This research aimed
to develop a protocol for DNA analysis of a minute blood stain subsequent to HemaTrace® testing.
Stains were collected and subjected to HemaTrace® testing. Swabs were then removed from the
HemaTrace® buffer solution and processed. DNA yields and STR DNA profiles were analysed
for both quantity and quality. Full profiles were reliably obtained from stains with diameters of
0.6 mm–0.7 mm, reflecting DNA concentrations between 0.0036 ng/µL and 0.007 ng/µL, varying
according to substrate characteristics. However, stains below a diameter of 0.6 mm should proceed
directly for DNA profiling. This protocol was also successfully performed on blood stains which
had undergone UV irradiation, although use of the reporting peak height threshold (lower than
the routine analytical threshold) was required to obtain useable profiles. We have been able to
demonstrate a protocol which, with minor adjustments to crime scene procedures, allows for both the
confirmation of the presence of human blood, together with the generation of useful DNA profiles.
Keywords: forensic biology; forensic DNA typing; HemaTrace®; lateral flow strip test; immuno-
chromatography; human blood; haemoglobin
1. Introduction
The discovery, subsequent testing and DNA typing of blood is vital for inferring
the potential presence of a person or sequence of events at a crime scene. Currently, the
standard blood collection protocols in our jurisdiction encourage suspected blood stains to
undergo presumptive testing and confirmatory testing, followed by DNA analysis.
An issue encountered with confirmatory testing is that it requires a portion of the stain
to be consumed. This is problematic for minute stains which may be too small to undergo
both confirmatory testing and DNA profiling, resulting in the sample being submitted for
DNA analysis only, thus bypassing confirmatory testing. This prevents the formation of
source-level propositions in court reports which has the potential to diminish evidential
value when cases proceed to trial. It is currently possible to obtain a DNA profile from trace
DNA samples with as little as 6 pg/µL–30 pg/µL of DNA [1–3]. Under these conditions,
source level attribution is very difficult, which limits the interpretation of circumstances
leading to the deposition of the DNA within the context of the crime. As technological
advances in laboratory operations have meant that the analysis of minute stains is now
possible, it is important that field operating procedures are updated to complement these
highly sensitive technologies.
Forensic. Sci. 2021, 1, 116–129. https://doi.org/10.3390/forensicsci1030011 https://www.mdpi.com/journal/forensicsci
Forensic. Sci. 2021, 1 117
Immunochromatographic cartridges are commonly employed for confirmatory testing
of biological stains. They employ an antibody-antigen-antibody sandwich where the
antigen is derived from the body fluid of interest (haemoglobin in blood, for example).
The test device consists of a membrane with a control zone, a test zone and a sample
well. An antibody raised against a specific antigen (from the body fluid of interest) is
immobilised at the test zone and if the sample of interest contains the antigen of interest,
an antibody-antigen compound is formed resulting in a pink line at the test site of the
card [4–9]. A positive result is indicated by a developed line at the test zone and the control
zone (as a result of bound labelled antibodies present at both sites) and is considered
valid only if the line at the control zone is observed [4–6]. Many such assays are available
including the Rapid Stain Identification Series [10], Hexagon OBTI Card (now Bluestar®
OBTI) [11] and ABA Card® HemaTrace® for blood [12].
In 2008, DNA profiles suitable for inclusion in the UK National DNA database were
extracted from the remaining buffer solution of the Hexagon OBTI immunochromato-
graphic assay by extracting DNA from a range of blood stains across various dilutions
applied to the assay using the Qiagen QIAamp DNA™ Minikit before amplifying it with
the AmpF`STR SGMplus™ kit [13]. Samples with a dilution of 1 in 105 or greater were
concentrated using YM-100 Centricon centrifugal filters. This method resulted in DNA
profiles being obtained from samples from a dilution lower than the previously reported
detection limit for the Hexagon assay.
Validation studies on the RSID™-Blood test in 2008 indicated that the sensitivity of the
kit had been specifically adjusted in order for a positive result for the presence of human
blood to be accompanied by a sufficient amount of biological material within the buffer
solution to produce a forensic STR profile [14]. Unlike the HemaTrace® and Hexagon
OBTI card systems which detect haemoglobin, RSID™-Blood is designed to detect traces
of glycophorin A, an erythrocyte membrane antigen specific to humans.
DNA profiles suitable for uploading to the United States database were obtained from
HemaTrace®, RSID™-Blood, RSID™-Saliva, and Hexagon OBTI card membranes by using
Low Copy Number (LCN) DNA profiling following a storage period of up to three months
in normal room temperature conditions [15]. LCN involved increasing the number of PCR
amplification cycles (from 28 to 34) and applying this to replicate samples. LCN analysis
is characterised by allele drop out and drop in [16] and for this reason it is not commonly
used in Australia and hence was not considered for this study.
In 2013, researchers in Japan laid the stained fabric on top of the test well of the
Hexagon OBTI card before applying several drops of the buffer fluid on top, allowing it
to diffuse through the stain, into the card, and along the membrane towards the testing
region [17]. They then performed direct PCR on the fabric itself, rather than any element of
the kit. This method does not conform to the typical in-field testing method used at crime
scenes in our jurisdiction and cannot be applied to stains on solid substrates such as wood.
Further, there is potential for false negatives due to the “high-dose hook effect” in the event
of a heavily saturated stain.
HemaTrace® assays were selected for use within our jurisdiction after in-house testing
validated their sensitivity and robustness for use in field work. In 2012, unpublished
internal research indicated that it was possible to obtain a forensic DNA profile from
the HemaTrace® membrane by adjusting the extraction buffer immersion time prior to
attempting extraction, and increasing the amount of buffer placed in the test well [18].
Further in-house studies indicated the membrane was not the most reliable source of DNA,
and instead found there was greater success in extracting DNA directly from the sample
collection swab, immersed in the buffer solution. (R. Driver, personal communication,
2 November 2015). Building on these in-house studies, the research described in this paper
aimed to develop a protocol that utilises minute stains for both confirmatory testing and
generation of a DNA profile from elements within the HemaTrace® testing kit. Experiments
were designed to analyse various aspects of the protocol including establishing a stain
size threshold for porous and non-porous substrates, determining the optimal swab for
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collection of stains from non-porous substrates, the efficacy of the protocol on degraded
stains, and comparing sample loss when using the protocol compared to submitting the
stain for DNA analysis without confirmatory testing. The ultimate aim was to make more
efficient use of minute stains and increase their evidential value.
2. Experimental Section
2.1. Stain Deposition
Earlier in-house experiments had established that full DNA profiles could be obtained
from blood stain sizes with a volume of 0.1 µL and this was used as our upper size limit.
We found it difficult to consistently pipette volumes of blood smaller than 0.1 µL, therefore
in order to create smaller stains we utilised four pieces of wire with diameters measuring
0.706 mm, 0.607 mm, 0.540 mm and 0.371 mm. All stain sizes were visible to the naked
eye in order to replicate the minute stains that would typically be encountered in the field
(Figure 1).
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Figure 1 Images of stain sizes (a) 0.1μL stain, (b) stain produced with 0.706 mm wire, (c) stain pro-
duced with 0.607 mm wire, (d) stain produced with 0.540 mm wire, (e) stain produced with 0.371 
mm wire. 
For sample deposition, the flat end of the wire was dipped into a 30 μL aliquot of 
blood and “stamped” onto the relevant substrate. The end of the wire was treated with 
i r . Images of stain sizes (a) 0.1 µL stain, (b) stain produced with 0.706 mm wire, (c) stain
produced with 0.607 mm wire, (d) stain produced with .540 mm wire, (e) stain pro uced with
0.371 mm wire.
l fl t i i i t 3 µL aliquot of
l st t t rele t s str t . t ire as treated ith
10% bleach then 70% ethanol and allowed to dry prior to the next collection to ensure no
carryover of excess blood or DNA product. This protocol was followed for every wire stain
deposition.
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2.2. HemaTrace® Testing
All relevant samples were collected and subjected to HemaTrace® testing (Abacus
Diagnostics, Los Angeles, CA, USA) according to the protocol recommended by the man-
ufacturer [7]. Following the appropriate incubation period, the substrate was removed
from the HemaTrace® buffer solution and placed into an AutoLys tube for automated DNA
analysis at the NSW Health Pathology, Forensic & Analytical Science Service (FASS). The
control samples were not subjected to HemaTrace® testing and swabs were placed into
AutoLys tubes immediately following stain collection.
2.3. Substrate Treatment
To ensure the substrates used in the study were DNA-free, the following treatment
was applied unless stated otherwise; wiping with 10% bleach, followed by 70% ethanol
before being exposed to UV treatment for 40 min using a Sanyo Denki® 254 nm UV-C
G30T8 30W light bulb (Sanyo Denki, Torrance, CA, USA) in a laminar flow hood.
2.4. Sensitivity Testing
To establish a stain size threshold for the collection and analysis of stains on non-
porous surfaces the following process was employed. Glass microscope slides (Livingstone
International, Mascot, NSW, Australia) were rendered DNA free as previously described.
Ten replicate bloodstains of five sizes (0.1 µL, 0.706 mm, 0.607 mm, 0.540 mm and 0.371 mm)
were deposited onto the treated microscope slides and left to dry before being collected by
swabbing the stains (n = 50). A single swab method was utilised whereby a small aliquot
of sterile water was deposited on one side of the swab. The wet side of the swab was then
rubbed against the stain to collect it. The swab was then rotated, and the dryer side of
the swab was used to finish the collection. This method of swabbing was used for the
collection of all swabbed stains.
2.5. Effect of Substrate
This experiment was designed to determine the impact of substrate on the sensitiv-
ity threshold established in the sensitivity study. The substrates selected are frequently
encountered at crime scenes: two types of fabric (cotton and elastane), and one wooden
substrate (H4 chemically treated pine, commonly found at outdoor crime scenes).
Fabric was placed into boiling water for 30 min, before being air dried and exposed
to UV light for 40 min using a Sanyo Denki® 254 nm UV-C G30T8 30W light bulb (Sanyo
Denki, Torrance, CA, USA) in a laminar flow hood. The fabric was cut into squares
measuring approximately 5 mm × 5 mm prior to stain placement, thereby negating the
need for excision of the stain.
The wood was scrubbed using a household detergent followed by the bleach, ethanol
and UV treatment as described above.
Ten replicate bloodstains of two different diameters (0.706 mm and 0.607 mm) were
deposited onto the substrates and left to dry. Stains on the wood substrate were collected
by swabbing, while the swatches were placed whole in the HemaTrace® buffer (Abacus
Diagnostics, Los Angeles, CA, USA) and remained whole for subsequent analyses (n = 20,
for each substrate).
2.6. Swab Comparison
This experiment tested the hypothesis that the ethylene oxide (EO) treated rayon
Dryswabs™ (Medical Wire & Equipment, Corsham, UK) used by the New South Wales
(NSW) Police Force and FASS for most protocols might be equally as suitable as the
cotton swabs provided with the Abacus ABAcard® HemaTrace® (Abacus Diagnostics, Los
Angeles, CA, USA) “Crime Scene Kits”.
Three replicate bloodstains of three diameters (0.1 µL, 0.706 mm and 0.607 mm) were
deposited onto DNA free microscope slides and left to dry before being collected with the
two different swab types (n = 18).
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2.7. DNA Loss Due to HemaTrace® Analysis
The DNA obtained from samples collected and sent directly for DNA analysis (i.e., con-
trol samples) was compared with the quantity obtained from samples that underwent
HemaTrace® treatment prior to DNA extraction.
For each variable, three replicate bloodstains of three diameters (0.1 µL, 0.706 mm and
0.607 mm) were deposited onto UV treated microscope slides (Sail Brand, Shanghai, China)
and left to dry before collection (n = 36).
2.8. Effect of UV Irradiation
This study investigated the effectiveness of the HemaTrace® protocol on stains which
had been exposed to UV irradiation. The intention was to mimic crime scene stains which
had been aged or weathered by sunlight.
Ten replicate bloodstains of two diameters (0.706 mm and 0.607 mm) were deposited
onto treated microscope slides and left to dry before being exposed to UV light, 13 cm
away from a Sanyo Denki 254 nm UV-C G30T8 30W light bulb in a laminar flow hood for
periods of 15, 30 and 45 min prior to collection (n = 60).
2.9. DNA Analysis
2.9.1. DNA Extraction
Lysis of samples was completed using the MicroLab® AutoLys STAR robotic worksta-
tion (Hamilton Company, Reno, NV, USA), using the lysis buffer provided with the Applied
Biosystems™ PrepFiler® Automated Forensic DNA Extraction Kit (Thermo Fisher Scien-
tific, Waltham, MA, USA). Following lysis, DNA extraction (purification) was completed
using the remaining components of the PrepFiler® Automated Forensic DNA Extraction
Kit according to the manufacturer’s recommended protocol [19]. This kit utilises magnetic
particle-based chemistry to capture and purify DNA and was completed on the Freedom
EVO® 150 robotic workstation (Tecan Australia, Port Melbourne, VIC, Australia).
The DNA extracts were quantified using the Applied Biosystems Quantifiler® Trio
DNA Quantification Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the
manufacturer’s recommended protocol. PCR set up was also performed on a Freedom
EVO® 150 workstation (Tecan Australia, AUS). Real time PCR was undertaken using an
Applied Biosystems 7500 Real Time PCR instrument (Thermo Fisher Scientific, Waltham,
MA, USA) according to the manufacturer’s recommended protocol [20].
2.9.2. DNA Amplification and Capillary Electrophoresis
A subset of samples from each experiment was selected for amplification and geno-
typing. To obtain a representative range of samples, the samples were selected based on
the DNA quantity, from a range of quantification values, to observe DNA profile quality
across a range of DNA quantities.
Using a Freedom EVO® 150 workstation (Tecan Austraila, Port Melbourne, VIC,
Australia), the PowerPlex® 21 Amplification System (Promega Corporation, Madison, WI,
USA) was employed according to the manufacturer’s recommended protocol [21], with
the exception that 29 cycles and a template input of 0.7 ng, rather than the manufacturer
recommendation of 30 cycles and 0.5 ng input, was used. Amplification was performed in
a GeneAmp® PCR System 9700 Thermal Cycler (Thermo Fisher Scientific, Waltham, MA,
USA) using the following protocol: initial PCR activation for 1 min at 96 ◦C; 29 cycles of
denaturation for 10 s at 94 ◦C, annealing for 1 min at 59 ◦C and extension for 30 s at 72 ◦C;
and a final extension of 10 min at 60 ◦C [22].
The amplified product was prepared for capillary electrophoresis using a Freedom
EVO® 150 workstation (Tecan Australia, Port Melbourne, VIC, Australia). The manufac-
turer’s protocol [21] was followed with the exception that for automated set up, double
the reaction volume was used, with 2 µL of amplified product and 0.75 µL of internal lane
standard per sample. Capillary electrophoresis was performed on an Applied Biosystems
3500xL Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA).
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2.9.3. Genotyping
Profiles were analysed using Applied Biosystems™ Gene Mapper® ID-X Software
using either version 1.5 or 1.6 (Thermo Fisher Scientific, Waltham, MA, USA) with: peak
height ratio minimum threshold of 0.60; homozygous peak height threshold of 700 relative
fluorescence units (RFU); and heterozygous peak analysis threshold of 175 RFU (in the
first instance). Following initial analysis, if it appeared there may be further data below
this threshold, the profiles were reanalysed at the validated FASS reporting threshold of
80 RFU.
Profiles were determined to be suitable if they were deemed “uploadable” profiles.
In our jurisdiction “uploadable results” are defined as profiles containing greater than or
equal to 12 reportable alleles, the threshold to be uploaded to our DNA database.
3. Results
3.1. Sensitivity
Determining the sensitivity of the method was a two-step process. First, we com-
pared the relationship between DNA quantity and “uploadable results” to determine the
minimum DNA concentration to consistently produce useable profiles. This minimum con-
centration was equated with a minimum stain size. This not only assisted in determining
a threshold, but also made it easier to translate these findings into useful information for
crime scene examiners who will be visually assessing stains for size suitability.
Full profiles were reliably obtained from samples down to 0.005 ng/µL of DNA,
representing a DNA template input of 0.075 ng per PCR. Samples with this concentration
also consistently exceeded the peak height threshold of 175 RFU for heterozygote alleles
and 700 RFU for homozygote allele designation.
When comparing this DNA concentration to stain sizes, Figure 2 shows that stains of
0.1 µL and those produced using the 0.706 mm wire exceeded the 0.005 ng/µL threshold.
Stains of this size also consistently resulted in full profiles (42 reportable alleles), while
those produced with the smaller wire sizes had inconsistent numbers of reportable alleles.




Figure 2. Stain size versus DNA concentration across ten replicates. The dashed line represents the 0.005 ng/μL concen-
tration threshold observed to produce full STR profiles in this dataset. Error bars represent standard deviations. 
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*all cotton replicates resulted in full profiles and as such there is no specific data for partial profiles. 
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a DNA concentration of 0.005 ng/μL or more, representing a DNA template input of 0.075 
ng. Samples with this concentration also consistently exceeded the required peak height 
thresholds. Stains from the 0.607 mm diameter wire had a larger variation in peak heights 
between samples, with some exceeding the usable profile thresholds, and others failing to 
pass all thresholds. However, the stains produced with the 0.706 mm diameter wire re-
sulted in more consistent profiles with less variation in peak heights (Figure 3). 
A full profile was obtained from only one wood sample which had a DNA concen-
tration of 0.007 ng/μL (0.105 ng of DNA template), with peak heights from samples below 
0.007 ng/μL consistently falling below the 700 RFU threshold for homozygote designation. 
On average, neither stain size resulted in a concentration consistently above 0.007 ng/μL, 
Figure 2. Stain size versus DNA c centration across ten replicates. The dashed line represents the
0.005 ng/µL concentration threshold observed to produce full STR profiles in this datas t. Error bars
represent standard deviations.
3.2. Effect of Substrate
Table 1 provides a summary of the recommended stain threshold sizes for each substrate.
All cotton samples selected for amplification provided full profiles. The lowest DNA
concentration was 0.0036 ng/µL, representing a DNA template input of 0.054 ng.
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Table 1. Summary of all threshold DNA concentrations to obtain a useful DNA profile, with





Amount (ng) Required for:
Smallest Stain Size (mm)
Required for:
12+ Alleles Full Profile 12+ Alleles Full Profile 12+ Alleles Full Profile
Glass 0.0014 0.005 0.021 0.075 0.607 0.706
Cotton 0.0036 * 0.0036 0.054 * 0.054 0.607 * 0.607
Elastane 0.00175 0.005 0.026 0.075 0.607 0.706
Wood 0.0032 0.007 0.048 0.105 0.607 0.706
* all cotton replicates resulted in full profiles and as such there is no specific data for partial profiles.
Both stain sizes of 0.706 mm and 0.607 mm for cotton exceeded the requirements for a
useable profile, and resulted in full profiles.
Uploadable profiles were often (but not always) obtained from elastane samples with
a DNA concentration of 0.005 ng/µL or more, representing a DNA template input of
0.075 ng. Samples with this concentration also consistently exceeded the required peak
height thresholds. Stains from the 0.607 mm diameter wire had a larger variation in peak
heights between samples, with some exceeding the usable profile thresholds, and others
failing to pass all thresholds. However, the stains produced with the 0.706 mm diameter
wire resulted in more consistent profiles with less variation in peak heights (Figure 3).
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A full profile was obtained from only one wood sample which had a DNA concentra-
tion of 0.007 ng/µL (0.105 ng of DNA template), with peak heights from samples below
0.007 ng/µL consistently falling below the 700 RFU threshold for homozygote designation.
On average, neither stain size resulted in a concentration consistently above 0.007 ng/µL,
however the stains produced by the 0.706 mm diameter wire had a higher average con-
centration, and the only full profile came from a stain produced with the 0.706 mm wire.
Stains from the 0.706 mm wire also generated profiles which more frequently exceeded the
700 RFU homozygote threshold. These results indicate that for unsealed wooden (semi-
porous) substrates, stains produced with the 0.607 mm diameter wire are an appropriate
minimum size threshold for useable profiles. Figure 3 provides a comparison between each
substrate and stain sizes, detailing the differences in peak height and allele count for each.
3.3. Swab Comparison
A comparison of DNA concentrations yielded from both HemaTrace® and EO treated
rayon Dryswab™ swabs is shown in Figure 4.




Figure 4. Comparison of; (a) DNA concentration, (b) average allele peak height and (c) number of 
reportable alleles for stain sizes and swab type. 
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covering similar numbers of alleles, meeting the requirement for uploadable profiles for 
all stain sizes. 
3.4. DNA Loss Due to HemaTrace® Analysis 
Figure 5 provides a comparison between DNA recovered from blood stains not sub-
ject to HemaTrace®and blood stains processed using the HemaTrace® protocol. 
For stains of 0.1 μL and those produced using the 0.706 mm wire, there is a noticeable 
drop in DNA concentration for samples subject to HemaTrace®. A Shapiro–Wilk test 
showed that the DNA concentration data were not normally distributed for the case of 
HemaTrace® applied to 0.1 μL stains (p = 0.012). A Kruskal–Wallis test revealed significant 
differences between treatments (p = 0.019) and amongst stain sizes (p < 0.001). The data 
were log transformed and a subsequent Shapiro–Wilk test demonstrated a normal distri-
bution for all cases. An ANOVA was applied to the log transformed data which demon-
strated there was no significant interaction between treatment (HemaTrace® or not) and 
stain size (p = 0.605). It also indicated significant differences between treatments (p < 0.001) 
and amongst stain sizes (p < 0.001), supporting the Kruskal–Wallis test on untransformed 
data. 
Similarly, there is a loss in peak height for samples subject to HemaTrace®. A 
Shapiro–Wilk test showed that the peak height data were not normally distributed for the 
. ( ) c t ( ) ll l i t (c) n er of
re rta le alleles f r stai sizes a s a ty e.
s s t e ifferences in the yiel et ee
s ll t ree stai sizes ere not statistical y significant (p = 0.70).
t t f ti l it t t fil l t , -
ri si ilar numbers of alleles, meeting the requirement for upload ble profiles for all
stain sizes.
Forensic. Sci. 2021, 1 124
3.4. DNA Loss Due to HemaTrace® Analysis
Figure 5 provides a comparison between DNA recovered from blood stains not subject
to HemaTrace® and blood stains processed using the HemaTrace® protocol.
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amongst stain sizes (p < 0.001), supporting the Kruskal–Wallis test on untransformed data.
Similarly, there is a loss in peak height for samples subject to HemaTrace®. A Shapiro–
Wilk test showed that the peak height data were not normally distributed for the case of
HemaTrace® applied to 0.1 µL stains (p = 0.006) and no HemaTrace® applied to 0.607 mm
stains (p = 0.027). Log transformation did not normalise the data for the case of no
HemaTrace® applied to 0.607 mm stains (p = 0.023). A Kruskal–Wallis test demonstrated
significant differences between treatments (p = 0.019) and amongst stain sizes (p < 0.001).
These results support those obtained for the DNA concentration data, with uploadable
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profiles obtained for all samples regardless of whether the sampled underwent HemaTrace®
processing.
3.5. Effect of UV Irradiation
None of the UV irradiated samples exceeded the 0.005 ng/µL concentration threshold
observed in the sensitivity study to produce useable STR profiles. Larger stains contained
a higher average concentration of DNA, as expected. Stains produced with the 0.607 mm
diameter wire and degraded for 45 min, yielded no DNA.
When analysed using the standard analysis threshold of 175 RFU, only one sample
exceeded the minimum requirement of 12 reportable alleles. After reanalysing the profiles
using the lower reporting threshold of 80 RFU, the number of uploadable profiles increased
to five samples, ranging in concentration from 0.0005 ng/µL to 0.0017 ng/µL. Table 2
provides a comparison of samples which provided uploadable profiles following reanalysis
at 80 RFU.
Table 2. Reportable alleles for the samples exposed to UV irradiation analysed with 175 RFU and 80
RFU thresholds.







0.607 15 min 0.0007 1 14
0.706 15 min 0.0010 4 13
0.706 15 min 0.0005 2 14
0.706 30 min 0.0009 15 29
0.706 45 min 0.0017 3 22
4. Discussion
4.1. Sensitivity
Our results demonstrate the feasibility of obtaining reportable DNA profiles from
swabs of minute blood stains that have been subjected to HemaTrace® analysis. Consis-
tently high numbers of reportable alleles were obtained down to 0.005 ng/µL of DNA,
or 0.075 ng of template DNA per PCR reaction, with allele peak heights exceeding the
laboratory RFU thresholds at this concentration. This concentration of 0.005 ng/µL was
consistently observed in blood stains from 0.1 µL blood volumes and those produced with
the 0.706 mm diameter wires.
Conversely, stains from smaller wires resulted in partial, yet still often uploadable,
STR profiles. In some samples, concentrations down to 0.0007 ng/µL resulted in partial
profiles of 29 alleles or more, however at this concentration homozygous alleles were
observed to fail the 700 RFU threshold required for homozygous designation and were
thus only counted as one allele.
4.2. Effect of Substrate
Our analysis of the effect of substrate on DNA recovery aligns with previous re-
search which found that substrates (such as calico, flannelette and cotton) soaked in
the HemaTrace® buffer yielded a higher quantity of DNA than surfaces which required
swabbing to collect the blood first (such as wood or plastic), concluding that swabbing
introduced another process through which DNA could be lost or left behind [23].
The differences observed between our cotton and elastane sensitivity threshold con-
centrations may be explained by earlier research which observed that a looser weave fabric,
such as cotton, may absorb and then subsequently release a greater amount of DNA into
its surrounding solution when compared to a tighter weave, such as elastane [24].
While the higher blood stain volume required for amplification of samples collected
from wood may be explained by the mechanism of swabbing and the loss of cells into a
Forensic. Sci. 2021, 1 126
porous and uneven substrate surface, this mechanism does not explain the higher DNA
concentration required in order to obtain full profiles from the wood substrate samples. It is
possible that the wood substrate may be causing PCR inhibition. Compounds within wood,
such as phenolic compounds of the lignin metabolite, can inhibit PCR [25,26]. Additionally,
chemicals used in the treatment of our specific wood substrate are known inhibitors. H4
treated timber undergoes chemical treatment which allows it to be resistant to decay
and termites, making it suitable for use outside and in-ground. This treatment process
involves exposure to three types of preservatives; alkaline copper quaternary (ACQ),
copper azole (CA) and copper chrome and arsenic (CCA) [27]. A key element in each of
these treatment types is copper, a metal ion which has been found to cause inhibition in the
PCR process [28,29], along with arsenic which has also been shown to potentially inhibit
the efficacy of PCR [30]. However, none of the profiles from the wood samples displayed
signs of inhibition, and successful amplification of the internal PCR control (IPC) in each
qPCR performed on the substrate samples indicated that no wood substrate sample from
this investigation experienced inhibition. A similar effect was observed in a study seeking
to recover trace DNA from fired cartridge cases (ammunition). DNA recovery was far less
from fired cartridge cases which were brass (containing copper), than from those that were
nickel, in spite of the absence of any inhibition as indicated by the IPC [31].
There was much greater variation in allele peak heights between loci for wood than for
cotton. This may indicate that the DNA collected from wood is more degraded, although
the mechanism of this degradation is unknown (it may be facilitated by copper). This is
supported by degradation index values for samples collected from the wood substrate
frequently nearing or exceeding a value of 1.0, which indicates slight to moderate DNA
degradation (data not shown) [20].
The requirement for a larger volume of blood stain for a useable profile should be kept
in mind when processing stains which have been collected from wood samples treated with
chemicals, particularly those which enable the preservation of these timbers in outdoor
environments.
4.3. DNA Loss Due to HemaTrace® Analysis
The DNA loss (in terms of both quantity and peak heights) from HemaTrace® anal-
ysis is not entirely surprising. It is expected that when a substrate containing a sample
undergoes more processes and tube transfers, the DNA remaining in the substrate will be
reduced. This loss can be attributed to the time spent in the HemaTrace® buffer and is sup-
ported by our in-house experiment results which indicate that the buffer does contain some
DNA post incubation. It is because of these losses that this protocol has a recommended
stain size sensitivity of approximately 0.7 mm, with any stain size below this being sent
straight for DNA analysis to maximise the potential for a useable DNA profile.
4.4. Effect of UV Irradiation
Blood stains deposited in outdoor environments and exposed to UV irradiation
will result in fewer useable DNA profiles after HemaTrace® processing but our results
demonstrate that it is possible to develop a partial profile from DNA quantities as low
as 0.0005 ng/µL using the lower reporting threshold (80 RFU). However, with little data
available as to the concentration of DNA found in stains which have undergone natural
degradation, rather than artificial degradation, such as in our study, it is difficult to deter-
mine at what level of exposure this protocol will cease to become suitable for use. Given
that the lamp used in this investigation is intended for germicidal treatment of a laminar
flow hood using UV-C rays [32], it is likely that it degrades DNA more than might occur in
sunlight, which primarily consists of lower energy UV-A or UV-B rays [33].
Additional research (data not shown) indicated that swabs/swatches containing 1 µL
blood stains may be able to be stored in the HemaTrace® buffer solution for an extended
period of time (up to 3 months) and still elicit an uploadable profile. It would be beneficial
for further studies to be undertaken to replicate these storage studies with varying stain
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sizes more in line with those used in the sensitivity testing. Similarly, other in-house
experiments (data not shown) indicated that this method has potential to be used on
diluted blood (up to 1:300 dilution factor), and from alternative substrates such as concrete
or tiles, however, further studies are required to accurately determine thresholds.
5. Conclusions
This study investigated factors impacting on DNA recovery from swabs and swatches
which had first been subjected to HemaTrace® testing to confirm the presence of human
blood, with a particular focus on minute stains which might otherwise not be subjected to
confirmatory testing. The best results were obtained from swabs when DNA concentrations
were above 0.005 ng/µL for stains that were collected from non-porous surfaces such as
glass. This is equivalent to 0.075 ng (or 75 pg) of template DNA in the PCR, and corresponds
to a stain size threshold of approximately 0.7 mm. The substrate from which the stain was
collected impacted the recoverability of the sample; cotton fabric was found to have a stain
size threshold of 0.6 mm for successful DNA recovery, and elastane 0.7 mm. Samples from
wood resulted in partial profiles at a 0.7 mm stain size, with larger stain sizes recommended
to achieve full profiles from this substrate.
Stains produced using the 0.607 mm wire resulted in partial profiles from glass,
elastane and wooden substrates and would still be useful in casework for exclusionary
purposes. Stains smaller than this should be collected and sent for DNA analysis without
confirmatory testing as results indicate that DNA loss is suffered when stains of this size
are subjected to HemaTrace® testing prior to DNA analysis.
There was no statistically significant difference in DNA recovery between cotton or
rayon swabs when collecting stains from non-porous surfaces. However, in-house testing
is recommended for other swabs if they differ from those used in the present study.
Analysis of the stains with an 80 RFU peak height threshold for capillary electrophore-
sis resulted in partial profiles from degraded stains with as little as 0.001 ng/µL of DNA
(equivalent to 0.015 ng (or 15 pg) of template DNA in the PCR).
With respect to processing exhibits or scenes for the presence of blood, general pro-
tocols suggest that any search should proceed in a sequence from least destructive to
most destructive. This should ideally include the use of white light and UV/415nm light
searching, followed by presumptive and confirmatory testing. It is anticipated that stains
the size of those used in this study would likely preclude presumptive testing due to the
risk of their consumption (e.g., Hemastix® or orthotolidine), or dilution of the stain due to
the application of additional chemical mixtures (e.g., luminol). The use of a non-destructive
presumptive test (such as light sources) prior to HemaTrace® testing would provide a
useful indicator of the presence of blood without risking the integrity of the sample.
In instances where caseworkers encounter minute blood stains and where the source
level link between a confirmed blood sample and a DNA profile is imperative in case
reporting, the authors further recommend:
• A preference to bypass presumptive testing which may result in the consumption of
part of the stain.
• Consideration of stain size and whether it is suitable for HemaTrace® testing prior to
DNA analysis, noting that the swatch or swab used for the collection and subsequent
HemaTrace® testing of the blood stain can later be used to develop a DNA profile for
stains of 0.6 mm–0.7 mm or greater.
• Consideration of substrate type, recognizing that non-porous substrates require a
larger stain size (greater than 0.7mm) to achieve a useable DNA profile using this
technique.
• Consideration of other inhibitory factors of the substrate itself.
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